logo

FDA Calendar

Share
Company Name G1 Therapeutics, Inc.
Drug Name Trilaciclib (NDA)
Event Name FDA decision on trilaciclib for small cell lung cancer patients being treated with chemotherapy
Event Date 02/15/2021
Outcome Date
Outcome
Drug Status Priority Review
Rival Drugs
Market Potential
Other Approvals
News
Return to FDA Calendar